Unused potential of lipid-lowering therapy in very high-risk patients with atherosclerotic cardiovascular disease. A retrospective data analysis

CONCLUSION: Switch to high-intensity statins and use of ezetimibe and PCSK9i was low in chronic ASCVD patients. Even though statin intake was high in high-risk patients, target levels were still not reached.PMID:38664125 | DOI:10.1016/j.numecd.2024.03.007

Source: Atherosclerosis - April 25, 2024 Category: Cardiology Authors: Sarah B Pohl Christiane Engelbertz Holger Reinecke Nasser M Malyar Matthias Meyborg Tobias J Brix Julian Varghese Katrin Gebauer Source Type: research